Background Ion channels play an important role in tumorigenesis and progression of
cervical cancer. Multiple long non‐coding RNA genes are widely involved in ion channel …

Purpose Cervical cancer (CC) is a major risk for health of modern women. Immune-related
long non-coding RNAs (lncRNAs) can also serve as prognostic markers of overall survival …

Background Several immune-associated long non-coding RNA (lncRNA) signatures have
been reported as prognostic models in different types of cancers; however, the immune …

Purpose: Our research developed immune-related long noncoding RNAs (lncRNAs) for risk
stratification in cervical cancer (CC) and explored factors of prognosis, inflammatory …

Background Cervical cancer is the fourth most common gynecological tumor in terms of both
the incidence and mortality of females worldwide. Cervical squamous cell carcinoma …

Background Copy number variation (CNV) suggests genetic changes in malignant tumors.
Abnormal expressions of long non-coding RNAs (lncRNAs) resulted from genomic and …

Long non-coding RNAs (lncRNAs), which have little or no protein-coding capacity, caught a
particular interest since their potential roles in the cancer paradigm. As the most common …

Purpose The aim of the present study was to construct a novel long non-coding RNA
(lncRNA) signature to predict the prognosis of patients with cervical cancer (CC). Materials …

Cervical cancer is a tumor with the second highest morbidity and mortality in the world, and it
is also the most common cancer and the eighth lethal factor among malignant tumors in …

The progression, metastasis, and prognosis of cervical cancer (CC) is influenced by the
tumor immune microenvironment. Studies proved that long non-coding RNAs (lncRNAs) to …